Volume 1, Issue 7

2014pp 476—500

About the Cover

The cover for the issue of Oncoscience features Figure 3A (“MicroRNA-17 inhibits tumor growth by stimulating T-cell mediated host immune response”) from Li et al.

Editorials

NMI and EMT

Rajeev S. Samant, Lalita A. Shevde

https://doi.org/10.18632/oncoscience.55pp 476—477

PDF Full-Text

P-gp and taxanes

Jeroen J.M.A. Hendrikx, Jos H. Beijnen, Alfred H. Schinkel

https://doi.org/10.18632/oncoscience.56pp 478—479

PDF Full-Text

YAP as oncotarget in uveal melanoma

Fa-Xing Yu, Kang Zhang, Kun-Liang Guan

https://doi.org/10.18632/oncoscience.57pp 480—481

PDF Full-Text

Sources of CNS tumor heterogeneity

Fuyi Chen, Albert Becker, Joseph LoTurco

https://doi.org/10.18632/oncoscience.60pp 482—483

PDF Full-Text

Targeting protein synthesis in cancer cells

Yvan Martineau, David Müller, Stéphane Pyronnet

https://doi.org/10.18632/oncoscience.63pp 484—485

PDF Full-Text

Research Perspectives

Adaptors for disorders of the brain? The cancer signaling proteins NEDD9, CASS4, and PTK2B in Alzheimer’s disease

Tim N. Beck, Emmanuelle Nicolas, Meghan C. Kopp, Erica A. Golemis

https://doi.org/10.18632/oncoscience.64pp 486—499

PDF Full-Text

The combinatorial complexity of cancer precision medicine

Frederick Klauschen, Michael Andreeff, Ulrich Keilholz, Manfred Dietel, Albrecht Stenzinger

https://doi.org/10.18632/oncoscience.66pp 504—503

PDF Full-Text

Research Papers

Genomic quantitative real-time PCR proves residual disease positivity in more than 30% samples with negative mRNA-based qRT-PCR in Chronic Myeloid Leukemia

Ilaria S. Pagani, Orietta Spinelli, Elia Mattarucchi, Cristina Pirrone, Diana Pigni, Elisabetta Amelotti, Silvia Lilliu, Chiara Boroni, Tamara Intermesoli, Ursula Giussani, Luigi Caimi, Federica Bolda, Renata Baffelli, Eleonora Candi, Francesco Pasquali, Francesco Lo Curto, Arnalda Lanfranchi, Fulvio Porta, Alessandro Rambaldi, Giovanni Porta

https://doi.org/10.18632/oncoscience.65pp 510—512

View Abstract PDF Full-Text

Clinical characteristics and outcomes of pediatric oncology patients with aggressive biology enrolled in phase I clinical trials designed for adults: The university of Texas MD Anderson cancer center experience

Fernando F. Corrales-Medina, Cynthia Herzog, Kenneth Hess, Daniela Egas-Bejar, David S. Hong, Gerald Falchook, Pete Anderson, Cesar Nunez, Winston W. Huh, Aung Naing, Apostolia M. Tsimberidou, Jennifer Wheler, Sarina Piha Paul, Filip Janku, Eugenie S. Kleinerman, Razelle Kurzrock, Vivek Subbiah

https://doi.org/10.18632/oncoscience.68pp 522—521

View Abstract PDF Full-Text

MicroRNA-17 inhibits tumor growth by stimulating T-cell mediated host immune response

Haoran Li, Shaan Gupta, William W. Du, Burton B. Yang

https://doi.org/10.18632/oncoscience.69pp 531—539

View Abstract PDF Full-Text

Mitomycin C reduces abundance of replication forks but not rates of fork progression in primary and transformed human cells

Keffy Kehrli, Julia M. Sidorova

https://doi.org/10.18632/oncoscience.70pp 540—539

View Abstract PDF Full-Text